SREBF1 and colorectal carcinoma: To determine whether the radiation‐activated SREBP1/FASN/cholesterol axis contributes to the acquired radioresistance of CRC cells, we transfected siRNA targeting SREBP1 (termed as siSREBP1) into HCT‐8 cells.